2014 CME Symposia - Lunch Symposium B

Register for the CMHC today to sign up for these value-added CME/CE activities-at no additional cost!

Pre-registration for symposia will open at the end of August for CMHC registrants to make selections. There are no additional fees to attend. Symposia include meals or refreshments and seating is limited and on a first-come, first-serve basis.

CME Lunch Symposium B

Friday · 12:30 - 2:00pm

New Frontiers in Obesity Management: Advances in Neurobiological Treatment Strategies

Supported by an educational grant from Takeda Pharmaceuticals International, Inc., US Region and Orexigen

Symposium Overview

New discoveries related to physiologic neuroendocrine mechanisms that mediate appetite regulation and energy balance as well as the relationship between obesity and related comorbidities has created a need for education. This activity will review the recent advances in knowledge regarding the neurobiological basis of obesity, the complexities of central nervous system (CNS) involvement and how new and emerging therapeutic options work with the CNS to regulate body weight. Attendees will receive guidance on how to select obesity therapies that are safe, effective and individualized to support obese patients during various stages of weight loss.

Learning Objectives

  • Recognize and apply the clinical criteria for being overweight or obese and understand the implications of this classification on other health markers and disease states, including diabetes, heart disease and related disease states.
  • Incorporate evidence-based weight loss strategies for obese patients with multiple comorbidities based on the safety and efficacy profiles of current and emerging anti-obesity medications, so that potential risks and benefits are considered when planning treatment.
  • Describe the physiologic and neurobiological mechanisms and signals that regulate appetite contributing to weight gain and associated comorbidities.
  • Implement pharmacologic therapies that work through neurological and neurobiological targets for appetite regulation.

Preliminary Agenda & Faculty

12:30 - 12:40pm Evolving Concepts in Obesity and Comorbid Conditions: Opening Remarks Chairperson: Caroline M. Apovian, MD
12:40 - 1:00pm Weight-Centric Approaches to Cardiometabolic Disease Management Presenter: Lee M. Kaplan, MD, PhD
1:00 - 1:20pm Food for Thought: Neurobiological Concepts to Appetite Regulation and Weight Loss: Beyond Individual Control Presenter: Joshua Thaler, MD, PhD
1:20 - 1:40pm Advances in Therapeutic Interventions for Achieving and Maintaining Weight Loss Presenter: Louis J. Aronne, MD
1:40 - 2:00pm Complex Cases in Obesity: The Expert Faculty Panel "Weigh In" on Effective Weight Loss Strategies to Reduce Cardiometabolic Risk Interactive Case Presentation, Panel Discussions, and Audience Q&A
Moderator: Caroline M. Apovian, MD
Discussants: Louis J. Aronne, MD; Lee M. Kaplan, MD, PhD; Joshua Thaler, MD, PhD

Caroline M. Apovian, MD

  • Professor of Medicine
  • Boston University School of Medicine
  • Director, Center for Nutrition and Weight Management
  • Boston Medical Center
  • Boston, MA

Louis J. Aronne, MD

  • Sanford I. Weill Professor of Metabolic Research
  • Medical Director
  • Center for Weight Management
    & Metabolic Clinical Research
  • Weill-Cornell Medical College

Lee M. Kaplan, MD, PhD

  • Associate Professor of Medicine
  • Harvard Medical School
  • Director, Obesity, Metabolism & Nutrition Institute
  • Massachusetts General Hospital
  • Boston, MA

Joshua Thaler, MD, PhD

  • Assistant Professor
  • Div. of Metabolism, Endocrinology, and Nutrition
  • University of Washington Department of Medicine

View Complete Accreditation Details and Program Overview: CMHC Accreditation